Extraordinary general meeting

Superdry plc: ROM-Result of General Meeting: Approval of Proposed Disposal by Shareholder Vote

Retrieved on: 
Sunday, December 10, 2023
HTTPS, Extraordinary general meeting, Mass meeting

The total number of shares on the register at 6.30pm on 06 November 2023, being those eligible to be voted on at the General Meeting, was 99,038,348.

Key Points: 
  • The total number of shares on the register at 6.30pm on 06 November 2023, being those eligible to be voted on at the General Meeting, was 99,038,348.
  • A ‘Vote Withheld’ is not a vote in law and has not been counted in the calculation of the proportion of the votes ‘For’ and ‘Against’ a resolution.
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.

EQS-News: Shelly Group convenes Extraordinary General Meeting

Retrieved on: 
Sunday, December 10, 2023
CET, Ticker, Extraordinary general meeting, Internet of things

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Sofia / Munich, 17 November 2023 – Shelly Group AD (Ticker SLYG / ISIN: BG1100003166 ) ("Shelly Group"), a provider of IoT and smart building solutions based in Sofia, Bulgaria, convenes an Extraordinary General Meeting to be held on 18 December 2023 at 10.00 CET / 11.00 EET in Sofia, Bulgaria.
  • Further information can be found at:

EQS-News: MGI - Media and Games Invest SE: Appointment of Nomination Committee

Retrieved on: 
Tuesday, November 7, 2023
ATTN:, Committee, ISIN, Person, Annual general meeting, Stureplan, Oaktree Capital Management, MGI, SE, Extraordinary general meeting, Nomination, Holding company

MGI - Media and Games Invest SE: Appointment of Nomination Committee

Key Points: 
  • MGI - Media and Games Invest SE: Appointment of Nomination Committee
    The issuer is solely responsible for the content of this announcement.
  • October 27, 2023 - MGI - Media and Games Invest SE ("MGI" or the "Company", ISIN: SE0018538068; Ticker M8G; Nasdaq First North Premier Growth Market and Scale Segment Frankfurt Stock Exchange) announces that the members of the Nomination Committee have been appointed.
  • The fourth member of the Nomination Committee shall be the Chairman of the Board of Directors of the Company.
  • Shareholders who wish to submit proposals to the Nomination Committee can do so by mail to;
    MGI – Media and Games Invest SE, attn.

MGI - Media and Games Invest SE: Appointment of Nomination Committee

Retrieved on: 
Tuesday, November 7, 2023
ATTN:, Committee, ISIN, Person, Annual general meeting, Stureplan, Oaktree Capital Management, MGI, SE, Extraordinary general meeting, Holding company

MGI - Media and Games Invest SE: Appointment of Nomination Committee

Key Points: 
  • MGI - Media and Games Invest SE: Appointment of Nomination Committee
    October 27, 2023 - MGI - Media and Games Invest SE ("MGI" or the "Company", ISIN: SE0018538068; Ticker M8G; Nasdaq First North Premier Growth Market and Scale Segment Frankfurt Stock Exchange) announces that the members of the Nomination Committee have been appointed.
  • In accordance with the decision of the Extraordinary General Meeting of November 01, 2022, regarding the principles and instructions for the Nomination Committee of MGI, the three largest shareholders of the Company have the right to appoint one member of the Nomination Committee each.
  • The fourth member of the Nomination Committee shall be the Chairman of the Board of Directors of the Company.
  • Shareholders who wish to submit proposals to the Nomination Committee can do so by mail to;
    MGI – Media and Games Invest SE, attn.

EQS-News: fashionette AG – Business combination with The Platform Group GmbH & Co. KG

Retrieved on: 
Tuesday, November 7, 2023
Extraordinary general meeting, Islamabad Wildlife Management Board, Annual, Acquisition, TPG, EUR, ISIN, Heavy equipment, Security (finance)

fashionette AG – Business combination with The Platform Group GmbH & Co. KG

Key Points: 
  • fashionette AG – Business combination with The Platform Group GmbH & Co. KG
    The issuer is solely responsible for the content of this announcement.
  • fashionette AG – Business combination with The Platform Group GmbH & Co. KG
    Duessseldorf, 06 November 2023.
  • The Management Board of fashionette AG (ISIN DE000A2QEFA1, "fashionette") announces today that the planned acquisition of a 100% stake in The Platform Group GmbH & Co KG is expected to be completed in the near future.
  • The Annual General Meeting also approved the renaming of fashionette AG to The Platform Group AG.

Dufry shareholders approve the change of the company name to Avolta AG

Retrieved on: 
Tuesday, November 7, 2023
Extraordinary general meeting, News, Mass meeting, Dufry, Bank, Holding company

An Extraordinary General Meeting of Dufry AG was held today in Basel, Switzerland.

Key Points: 
  • An Extraordinary General Meeting of Dufry AG was held today in Basel, Switzerland.
  • At the meeting, the shareholders resolved to change the company name of Dufry AG to Avolta AG.
  • A total number of 99,885,200 shares was represented, corresponding to 66.36% of the total share capital of Dufry AG.
  • 1The voting result expressed in this news release is in percent of the votes represented at the Extraordinary General Meeting.

EQS-News: Postponement of publication of the 2022 annual report

Retrieved on: 
Tuesday, November 7, 2023
Extraordinary general meeting, Joint Admissions Board of Kenya, ESG, BX Swiss

Huenenberg, 3.11.2023 - As reported in the publication dated 31 October 2023, ESGTI Ltd (ticker: ESGTI) has asked BX Swiss AG for a Special Authorisation regarding the postponement of the publication of the annual accounts 2022 until 30 November 2023.

Key Points: 
  • Huenenberg, 3.11.2023 - As reported in the publication dated 31 October 2023, ESGTI Ltd (ticker: ESGTI) has asked BX Swiss AG for a Special Authorisation regarding the postponement of the publication of the annual accounts 2022 until 30 November 2023.
  • ESGTI informed its shareholders about the plan to spin-off ESG LifeSciences Ltd at the Extraordinary General Meeting on 30 June 2023.
  • The associated valuation correction of September 2023 is not only a material event after the balance sheet date, which must be disclosed in the notes of the annual accounts 2022.
  • In this this sense, ESGTI will announce and publish the audited annual accounbts 2022 to shareholders as soon as possible.

Shareholders of Abcam Approve Proposed Acquisition by Danaher

Retrieved on: 
Monday, November 6, 2023
Research, Finance, Genetics, Clinical Trials, Professional Services, Biotechnology, Health, Pharmaceutical, Science, Danaher, Youth justice in England and Wales, NYSE, High court, Court, Mass meeting, Acquisition, Transaction, Resolution, Extraordinary general meeting, Proxy, Danaher Corporation, DHR, England, Scheme, Management, Security (finance), Cryptocurrency, Abcam

Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) (‘Danaher’), today announced that its shareholders have approved the proposal for Danaher to acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’).

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, which entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) (‘Danaher’), today announced that its shareholders have approved the proposal for Danaher to acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’).
  • “With this approval, we are focused on moving swiftly toward transaction close and ensuring a successful transition to deliver maximum value to our shareholders, employees, and customers.”
    “We are thrilled shareholders have overwhelmingly approved the Transaction.
  • This outcome has arrived at the right time for Abcam to embark on the next chapter in its story within the Danaher family,” said Alan Hirzel, Chief Executive Officer of Abcam.
  • The Resolution was therefore passed by the requisite majority of Abcam Shareholders.

Orexo Q3 2023 Interim Report

Retrieved on: 
Thursday, November 2, 2023
Allergy, FDA, Extraordinary general meeting, Opioid overdose, EBITDA, Adrenaline, Novo Holdings A/S, Robin, SEK, Committee, Pharmaceutical industry

UPPSALA, Sweden, Nov. 2, 2023 /PRNewswire/ --

Key Points: 
  • ›     EBITDA of SEK -9.5 m (-32.4), EBITDA excluding costs for legal processes and external non-­repeating ­­clinical trials, SEK 13.3 m (14.3)
    ›     The first patent issued in the US for OX640, epinephrine rescue medication for allergic reactions
    ›     OX124, high-dose rescue medication for opioid overdose, refiled with the FDA
    ›     The MODIA® study didn't meet the ­primary end-points, but showed high rates of treatment ­response in both study arms, with no adverse events associated with the use of MODIA
    ›     Robin Evers elected as board member at the Extraordinary General Meeting.
  • He replaces ­Henrik ­Kjaer ­Hansen who has announced he will resign.
  • Kjaer Hansen, has instead been appointed ­c­­hairman of the Nomination Committee, representing Novo Holdings A/S

Orexo Q3 2023 Interim Report

Retrieved on: 
Thursday, November 2, 2023
Allergy, FDA, Extraordinary general meeting, Opioid overdose, EBITDA, Adrenaline, Novo Holdings A/S, Robin, SEK, Committee, Pharmaceutical industry

UPPSALA, Sweden, Nov. 2, 2023 /PRNewswire/ --

Key Points: 
  • ›     EBITDA of SEK -9.5 m (-32.4), EBITDA excluding costs for legal processes and external non-­repeating ­­clinical trials, SEK 13.3 m (14.3)
    ›     The first patent issued in the US for OX640, epinephrine rescue medication for allergic reactions
    ›     OX124, high-dose rescue medication for opioid overdose, refiled with the FDA
    ›     The MODIA® study didn't meet the ­primary end-points, but showed high rates of treatment ­response in both study arms, with no adverse events associated with the use of MODIA
    ›     Robin Evers elected as board member at the Extraordinary General Meeting.
  • He replaces ­Henrik ­Kjaer ­Hansen who has announced he will resign.
  • Kjaer Hansen, has instead been appointed ­c­­hairman of the Nomination Committee, representing Novo Holdings A/S